J Korean Soc Plast Reconstr Surg.
2000 May;27(3):270-275.
The Effects of Deferoxamine on the Oxygen Free Radical and Neutrophil in Ischemia-Reperfusion Injury
- Affiliations
-
- 1Department of Plastic & Reconstructive Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Abstract
-
Adequate circulation is indispensable for flap survival. Ischemia-reperfusion injury is
one of the causes of flap necrosis. Current evidence suggests that tissue damage associated
with ischemia-reperfusion injury and inflammatory responses may be mediated by oxygen free
radicals and neutrophils. Oxygen free radicals can directly alter structural component of
tissue, attack membrane phospholipids and produce the chemotactic factor for neutrophil
which is main cell in inflammatory reactions and an important source of oxygen free radicals.
Deferoxamine is well known as a powerful chelator of iron and free radical scavenger.
It is also known to decrease the skin flap necrosis. The purpose of this study is to evaluate
the effects of deferoxamine on the oxygen free radicals and neutrophils after
ischemia-reperfusion injury of skin flaps. A 6 x 3 cm sized island skin flap was made on the
left abdomen of rat and the epigastric pedicle was occluded for 6 hours. Thirty minutes
before reperfusion, the flaps were perfused with normal saline or deferoxamine. The flap
survival rates were assessed by computerized planimetry on the fifth day after reperfusion.
Tissues for assay of MDA and MPO were obtained at 6, 12, 24, 48 hours after reperfusion.
The results were as follows: 1. Deferoxamine administration groups improved flap survival
rates significantly compared to control groups (78.3+/-13.2%, 54.6+/-6.35%) (p = 0.0011).
2. The level of MDA was significantly lowered in deferoxamine administration groups compared
to control groups(p<0.05). The levels of MDA were increased over time in each group but,
the ircrement was steeper in control groups than that in deferoxamine administration groups.
In control groups, the increment between 6 and 12 hours was argest. 3. MPO content was increased
over time in each group but significantly low in deferoxamine administration groups compared
to control groups(p<0.05). The increment of control groups was steeper than that of
deferoxamine administration groups. We conclude that deferoxamine improve the flap survival
rates after reperfusion injury by inhibition of production of oxygen free radicals and neutrophil
influx via a free radical scavenger 8 anti-inflammatory action.